| Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 2139 | 2020 |
| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1559 | 2019 |
| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24, e1-e38, 2018 | 1377 | 2018 |
| Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel U Creutzig, MM van Den Heuvel-Eibrink, B Gibson, MN Dworzak, ... Blood, The Journal of the American Society of Hematology 120 (16), 3187-3205, 2012 | 706 | 2012 |
| Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update T Lehrnbecher, P Robinson, B Fisher, S Alexander, RA Ammann, ... Journal of Clinical Oncology 35 (18), 2082-2094, 2017 | 495 | 2017 |
| Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with … AH Groll, E Castagnola, S Cesaro, JH Dalle, D Engelhard, W Hope, ... The Lancet Oncology 15 (8), e327-e340, 2014 | 419 | 2014 |
| Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation T Lehrnbecher, R Phillips, S Alexander, F Alvaro, F Carlesse, B Fisher, ... Journal of clinical oncology 30 (35), 4427-4438, 2012 | 375 | 2012 |
| Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98 U Creutzig, M Zimmermann, D Reinhardt, M Dworzak, J Stary, ... Journal of Clinical Oncology 22 (21), 4384-4393, 2004 | 315 | 2004 |
| Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) C Cordonnier, S Einarsdottir, S Cesaro, R Di Blasi, M Mikulska, C Rieger, ... The Lancet infectious diseases 19 (6), e200-e212, 2019 | 292 | 2019 |
| Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the … M Hoenigl, J Salmanton-García, TJ Walsh, M Nucci, CF Neoh, JD Jenks, ... The Lancet Infectious Diseases 21 (8), e246-e257, 2021 | 290 | 2021 |
| Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. CB Foster, T Lehrnbecher, F Mol, SM Steinberg, DJ Venzon, TJ Walsh, ... The Journal of clinical investigation 102 (12), 2146-2155, 1998 | 275 | 1998 |
| Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93 T Lehrnbecher, D Varwig, J Kaiser, D Reinhardt, T Klingebiel, U Creutzig Leukemia 18 (1), 72-77, 2004 | 268 | 2004 |
| Variant genotypes of the low-affinity Fcγ receptors in two control populations and a review of low-affinity Fcγ receptor polymorphisms in control and disease populations T Lehrnbecher, CB Foster, S Zhu, SF Leitman, LR Goldin, K Huppi, ... Blood, The Journal of the American Society of Hematology 94 (12), 4220-4232, 1999 | 256 | 1999 |
| Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004 U Creutzig, M Zimmermann, JP Bourquin, MN Dworzak, G Fleischhack, ... Blood, The Journal of the American Society of Hematology 122 (1), 37-43, 2013 | 231 | 2013 |
| Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 M Rasche, M Zimmermann, L Borschel, JP Bourquin, M Dworzak, ... Leukemia 32 (10), 2167-2177, 2018 | 226 | 2018 |
| Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML … U Creutzig, M Zimmermann, T Lehrnbecher, N Graf, J Hermann, ... Journal of clinical oncology 24 (27), 4499-4506, 2006 | 223 | 2006 |
| An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus CB Foster, T Lehrnbecher, S Samuels, S Stein, F Mol, JA Metcalf, K Wyvill, ... Blood, The Journal of the American Society of Hematology 96 (7), 2562-2567, 2000 | 211 | 2000 |
| Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates WJ Steinbach, E Roilides, D Berman, JA Hoffman, AH Groll, I Bin-Hussain, ... The Pediatric infectious disease journal 31 (12), 1252-1257, 2012 | 201 | 2012 |
| Trends in the postmortem epidemiology of invasive fungal infections at a university hospital T Lehrnbecher, C Frank, K Engels, S Kriener, AH Groll, D Schwabe Journal of Infection 61 (3), 259-265, 2010 | 194 | 2010 |
| Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study J Donadieu, IA Larabi, M Tardieu, J Visser, C Hutter, E Sieni, N Kabbara, ... Journal of Clinical Oncology 37 (31), 2857-2865, 2019 | 185 | 2019 |
